Switzerland· 47473002
Miacalcic 200, Nasenspray
A calcitonin (salmon synthetic) product containing calcitoninum salmonis, registered in Switzerland by Future Health Pharma GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Calcitonin (salmon synthetic) is registered in 10 of 19 countries.
Countries holding a registration under ATC H05BA01 (calcitonin (salmon synthetic)), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 6 of them publish a price we can compare per daily dose
Calcitonin (salmon synthetic) · ATC H05BA01
10 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- calcitoninum salmonis
- Manufacturer
- Future Health Pharma GmbH
- Country
- Switzerland (CH)
- ATC code
- H05BA01
- ATC class
- Calcitonin (salmon synthetic)
- Defined daily dose
- 200 E, N
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680474730028Fl 1 StkCHF 59.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for calcitonin (salmon synthetic).
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Calcitonin (salmon synthetic) · interactions on record
6 records
- 1 severe
- 2 moderate
- 3 minor
Most severe, free to view
- EtelcalcetideH05BX04severe
- FoscarnetJ05AD01moderate
- LithiumN05AN01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H05BA01
Calcitonin (salmon synthetic), as other registers publish it.
- CanadaCALCIMARSANOFI-AVENTIS CANADA INC
- DenmarkCalcitonin "Orifarm"Orifarm A/S
- United StatesCalcitonin SalmonDr. Reddy's Laboratories, Inc.
- NetherlandsCalcitonine ERC 100 IE/ml, oplossing voor injectie en infusieEuro Registratie Collectief B.V.
- NetherlandsCalcitonine Eureco-Pharma 100 IE/ml, oplossing voor injectie en infusieEureco-Pharma B.V.
- NetherlandsCalcitonine-EssPharma 100 IE/ml, oplossing voor injectie en infusieEssential Pharma Limited
- FinlandCalsynarArmour Pharmaceutical Company Ltd.
- FinlandForcaltoninUnigene UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b225b206-2e21-4fce-a240-0b6000776c13 GET /v1/drugs/b225b206-2e21-4fce-a240-0b6000776c13?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "calcitoninum salmonis 200 UI",
"valid_from": "2022-05-01",
"limitations": "[{\"description\":\"Die Behandlungen bedürfen der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.<br>\\nOsteoporoseprävention: Bei akutem Knochenschwund aufgrund plötzlicher Immobilisierung wie zum Beispiel bei Patienten mit Osteoporose-Frakturen. Vergütungsdauer maximal 3 Monate.<br>\\nMorbus Paget (Osteitis deformans): Nur bei Patienten, die nicht auf alternative Behandlungen ansprechen oder bei denen alternative Behandlungen ungeeignet sind. Vergütungsdauer 3 Monate.<br>\\nBei Algodystrophie oder Sudeck-Syndrom (Neurodystrophische Störungen): Neurodystrophische Störungen aufgrund unterschiedlicher ätiologischer und prädisponierender Faktoren wie posttraumatische schmerzhafte Osteoporose, Reflexdystrophie, Schulter-Arm-Syndrom, Kausalgie und arzneimittelbedingte neurotrophische Störungen. Vergütungsdauer bis 6 Wochen.<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2018-02-01\"}]",
"galenic_form": "Nasenspray 200 E/Dosis",
"therapeutic_area": null,
"sl_inclusion_date": "1997-03-15",
"self_retention_pct": 10
}See everything about calcitonin (salmon synthetic).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.